Azitra, Inc. (NYSEAMERICAN:AZTR) Short Interest Update

Azitra, Inc. (NYSEAMERICAN:AZTR) was the target of a large decline in short interest during the month of April. As of April 15th, there was short interest totaling 557,165 shares, a decline of 77.1% from the March 31st total of 2,434,370 shares. Based on an average daily trading volume, of 825,420 shares, the days-to-cover ratio is currently 0.7 days. Currently, 3.4% of the shares of the company are short sold.

Azitra Price Performance

NYSEAMERICAN:AZTR traded up $0.01 during mid-day trading on Friday, reaching $0.22. The company’s stock had a trading volume of 361,942 shares, compared to its average volume of 1,068,785. Azitra has a 12-month low of $0.10 and a 12-month high of $2.66. The firm’s fifty day moving average price is $0.21 and its two-hundred day moving average price is $0.32.

About Azitra

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.